Recent 8-K filings for PBH

• May 13, 2026, 4:35 PM ET M&A materiality 0.75 neutral item 1.01item 2.02item 7.01item 9.01

  Prestige Consumer reports FY26 adj EPS $4.38; acquires LaCorium Health for $150M

  FY26 revenue $1,088.7M (-4.3% YoY); adjusted diluted EPS $4.38 vs $4.52 prior year.

• March 20, 2026, 7:59 PM ET M&A materiality 0.85 positive item 1.01item 7.01item 8.01item 9.01 ◈ Material Agreements

  Prestige Consumer Healthcare to acquire Breathe Right brand portfolio for $1.045B

  Acquisition includes Breathe Right, Dimetapp, Anbesol brands; trailing revenue $200M, EBITDA $95M.

• February 5, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 7.01item 9.01

  Prestige Q3 revenue $283.4M, down 2.4% YoY; adjusted EPS $1.14 vs $1.22

  GAAP diluted EPS $0.97; adjusted diluted EPS $1.14 (down from $1.22); net income $46.7M.

• November 6, 2025, 6:59 PM ET earnings materiality 0.65 positive item 2.02item 7.01item 9.01

  Prestige Consumer Q2 adj EPS $1.07 beats prior year; raises FY adj EPS guidance to $4.54-$4.58

  Q2 revenue $274.1M (-3.4% YoY); diluted EPS $0.86 vs $1.09; adjusted EPS $1.07.

• August 7, 2025, 7:59 PM ET earnings materiality 0.85 negative item 1.01item 2.02item 7.01item 9.01

  Prestige Q1 revenue down 6.6%, misses; acquires Pillar5 for CAD 150M, cuts FY26 outlook

  Revenue $249.5M (-6.6% YoY); diluted EPS $0.95 ($0.90 adjusted).

• May 8, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Prestige Q4 revenue $296.5M, adj EPS $1.32; FY25 adj EPS $4.52; FY26 outlook $4.70-4.82

  Q4 revenue $296.5M (+7.0% YoY, organic +7.9%); diluted EPS $1.00 GAAP, adjusted $1.32 (vs $1.02 prior year).

• February 6, 2025, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 7.01item 9.01

  Prestige Q3 FY2025 EPS $1.22 (+15% YoY); raises FY25 adjusted EPS outlook to ~$4.50

  Q3 revenues $290.3M (+2.7% YoY); record quarterly sales and EPS.

• November 7, 2024, 6:59 PM ET earnings materiality 0.60 positive item 2.02item 7.01item 9.01

  Prestige Consumer Healthcare Q2 revenue $283.8M, diluted EPS $1.09; reaffirms FY2025 outlook

  Revenue $283.8M (-0.9% YoY) slightly ahead of expectations; diluted EPS $1.09 vs $1.07 prior year.

• August 8, 2024, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 7.01item 9.01

  Prestige Consumer Q1 revenue $267.1M beats expectations; reaffirms FY2025 outlook

  Q1 GAAP EPS $0.98, adjusted EPS $0.90; revenue down 4.4% YoY but ahead of internal plan.

• May 14, 2024, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 7.01item 8.01item 9.01 ◈ Earnings Releases ×2

  Prestige Consumer Q4 revenue down 2.9%; adj. EPS $1.02; $300M buyback; FY2025 EPS guidance $4.40-$4.46

  Q4 revenue $277.0M (-2.9% ex-FX); non-GAAP adj. diluted EPS $1.02 vs $1.07 prior year.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.75 · Most common event earnings

6 positive 2 negative 4 neutral

source · PBH on sec.gov